Prentice Capital Management, LP / IMNM
Prentice Capital Management, LP’s Immunome Inc Position
Does Prentice Capital Management, LP own Immunome Inc (IMNM)? Not currently — the last reported position was 112.1K shares worth $1M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1M
Q4 2023
Shares
112.1K
% of Portfolio
+2.79%
Quarters Held
13
position exited
Position History IMNM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2023 | 112.1K | $1M | +2.79% |
| Q3 2023 | 112.1K | $936,294 | +2.88% |
| Q2 2023 | 112.1K | $886,956 | +2.83% |
| Q1 2023 | 431.9K | $2M | +4.62% |
| Q4 2022 | 498.1K | $1M | +1.20% |
| Q3 2022 | 791.8K | $4M | +2.61% |
| Q2 2022 | 791.8K | $3M | +1.04% |
| Q1 2022 | 792.3K | $5M | +1.07% |
| Q4 2021 | 806.5K | $10M | +2.26% |
| Q3 2021 | 517.2K | $13M | +3.18% |
| Q2 2021 | 517.2K | $9M | +2.14% |
| Q1 2021 | 332.0K | $11M | +3.49% |
| Q4 2020 | 416.7K | $4M | +1.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Prentice Capital Management, LP’s full portfolio or all institutional holders of IMNM.